MEASUREMENT METHODS - ANNOTATIONS
The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml ).
Term: autopsy
Accession: MMO:0000343
browse the term
Definition: A postmortem examination of a body to determine the cause of death or the character and extent of changes produced by disease.
Q
Cardf1
Cardiac cell morphology QTL 1
IDA
RGD
PMID:14532335
RGD:727992
NCBI chr13:11,929,449...45,417,941
Q
Eutr1
Estrogen induced uterine response QTL 1
IDA
RGD
PMID:16284801
RGD:1559292
NCBI chr 5:2,138,965...166,875,058
Q
Eutr2
Estrogen induced uterine response QTL 2
IDA
RGD
PMID:16284802
RGD:1559291
NCBI chr 5:34,730,116...104,251,008
Q
Gcr1
Gastric cancer resistance QTL 1
IDA
RGD
PMID:10706129
RGD:69698
NCBI chr 4:120,260,281...147,278,687
Q
Gcr2
Gastric cancer resistance QTL 2
IDA
RGD
PMID:10706129
RGD:69698
NCBI chr 3:8,658,162...27,494,778
Q
Gcs1
Gastric cancer susceptibility QTL1
IDA
RGD
PMID:10706129
RGD:69698
NCBI chr15:76,306,099...101,769,107
Q
Ginf1
Gastrointestinal inflammation QTL 1
IDA
RGD
PMID:19526527
RGD:2316974
NCBI chr 8:4,705,810...49,705,810
Q
Ginf2
Gastrointestinal inflammation QTL 2
IDA
RGD
PMID:19526527
RGD:2316974
NCBI chr 8:4,705,810...49,705,810
Q
Ginf3
Gastrointestinal inflammation QTL 3
IDA
RGD
PMID:19526527
RGD:2316974
NCBI chr17:49,920,154...86,533,673
Q
Mamtr2
Mammary tumor resistance QTL 2
IDA
RGD
PMID:14522903
RGD:724790
NCBI chr 2:7,887,772...12,654,247
Q
Mamtr3
Mammary tumor resistance QTL 3
IDA
RGD
PMID:14522903
RGD:724790
NCBI chr 2:32,373,770...43,665,178
Q
Mamtr4
Mammary tumor resistance QTL 4
IDA
RGD
PMID:14522903
RGD:724790
NCBI chr 2:16,491,740...61,491,740
Q
Renag1
Renal agenesis QTL 1
IDA
RGD
PMID:16845468
RGD:1580355
NCBI chr14:8,170,668...68,298,175
Q
Schws8
Schwannoma susceptibility QTL 8
IDA
RGD
PMID:25303613
RGD:11566050
NCBI chr 6:94,968,928...139,968,928
Q
Schws9
Schwannoma susceptibility QTL 9
IDA
RGD
PMID:25303613
RGD:11566050
NCBI chr 6:61,747,639...106,747,639
Q
Tcas11
Tongue tumor susceptibility QTL 11
IDA
RGD
PMID:16527513
RGD:1578522
NCBI chr 5:46,711,509...161,317,411
Q
Tcas7
Tongue tumor susceptibility QTL 7
IDA
RGD
PMID:15876484
RGD:1358147
NCBI chr19:24,817,978...39,654,489
Q
Tls1
T-lymphoma susceptibility QTL 1
IDA
RGD
PMID:10360666
RGD:619600
NCBI chr 5:90,450,144...135,450,144
Q
Tls2
T-lymphoma susceptibility QTL 2
IDA
RGD
PMID:10360666
RGD:619600
NCBI chr 7:80,221,299...109,401,111
Q
Tls3
T-lymphoma susceptibility QTL 3
IDA
RGD
PMID:10360666
RGD:619600
NCBI chr10:51,774,612...95,600,334
Q
Vetf1
Vascular elastic tissue fragility QTL 1
IDA
RGD
PMID:11526202
RGD:619605
NCBI chr 5:2,282,226...5,904,428
Q
Vetf2
Vascular elastic tissue fragility QTL 2
IDA
RGD
PMID:11526202
RGD:619605
NCBI chr10:41,142,633...86,142,633
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all